Will the key leader of non-benefit products, filler, continuously grow? The answer will be shown at KRW 100 billion

Will the filler market, which has been in the limelight as a non-benefit medication, become a limitless gold mine for the pharmaceutical industry?

The filler market became a market worth of KRW 90 billion last year, growing 10% up every year since 2011. Thus, 100 products of 47 companies are currently competing to capture the attraction.

Since filler is a non-benefit pharmaceutical product, i...